SR One related stories
All articles and analysis
Design Therapeutics snags $45m Series ADesign Therapeutics, which is developing treatments for serious degenerative disorders, has raised $45 million in Series A funding.
VC-backed Pandion Therapeutics appoints CEOCambridge, Massachusetts-based Pandion Therapeutics, a biotech company focused on treating autoimmune and inflammatory disease, has named Dr. Rahul Kakkar as CEO and a member of its board of directors. Also, Pandion has promoted Dr. Jo Viney, a founder of the company, to president and chief scientific officer. And, Vikas Goyal joins Pandion as senior vice president of business development. Pandion's investors include Polaris Partners, Versant Ventures, Roche Venture Fund, SR One and BioInnovation Capital.
- Pandion Therapeutics lands funding
Cambridge, Massachusetts-based Pandion Therapeutics, a biotech company focused on treating autoimmune and inflammatory disease, has secured an undisclosed amount of funding. The investor was JDRF T1D Fund.
- ResMed to buy digital therapeutics firm Propeller Health for $225 mln
ResMed has agreed to acquire Madison, Wisconsin-based Propeller Health, a digital therapeutics company, for $225 million. DLA Piper is serving as legal counsel to ResMed on the deal. And, Allen & Company LLC is providing financial advice to Propeller while Fenwick & West LLP is serving as legal counsel. Propeller Health's backers include Aptar Pharma, Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One.
- Decibel Therapeutics rakes in $55 mln Series C
Boston-based Decibel Therapeutics, a developer of treatments for hearing loss and hearing-related disorders, has raised $55 million in Series C financing. The investors included Third Rock Ventures, GV, SR One, Regeneron Pharmaceuticals, Foresite Capital, Bessemer Venture Partners, Schroder Adveq, S-Cubed and Longevity.
- Biotech company Nimbus Therapeutics garners $65 mln
Cambridge, Massachusetts-based Nimbus Therapeutics, a biotechnology company, has secured $65 million in funding. The investors included Atlas Venture, SR One, Lilly Ventures, Bill Gates, Pfizer Venture Investments, Lightstone Ventures and Schrödinger.
- Digital therapeutics company Propeller Health rakes in $20 mln
Madison, Wisconsin-based Propeller Health, a digital therapeutics company, has raised $20 million in funding. Aptar Pharma led the round with participation from return backers Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One.